Compugen (CGEN) EBITDA Margin Growth (5y) (2014 - 2018)
Analysis
Compugen (CGEN) EBITDA Margin Growth (5y) (2014 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Compugen | 241.50 Mn | 155.89 Mn | -92,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 23,414.00 |
| Mar 31, 2018 | 244,806.00 |
| Dec 31, 2015 | 120,178.00 |
| Jun 30, 2015 | -301,664.00 |
| Mar 31, 2015 | 94,204.00 |
| Dec 31, 2014 | 778,698.00 |
| Sep 30, 2014 | -237,568.00 |